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with E. faecalis and G. morbillorum, and (2) all cardiac
valves were replaced in 1 operation. To the best of our
knowledge, the current report is the first to describe success-
ful quadruple valve replacement for acute endocarditis.
E. faecalis is known to cause endocarditis, as isG. morbil-
lorum, but a simultaneous infection with both organisms has
been described only once.1 Infection with E. faecalis can be
extensive, as reported by Krake and colleagues2 in a patient
with involvement of all cardiac valves. The patient in this
case report did not undergo surgical treatment and subse-
quently died of sepsis.2
Involvement of all 4 heart valves can be observed with in
other pathologic processes. Chiappini and colleagues3 re-
ported on a patient with severe dysfunction of all valves
secondary to carcinoid spread from the ileum. Their patient
underwent valve replacement (tricuspid, pulmonary) and
valve repair (aortic, mitral) with a good recovery. Hossack
and colleagues4 also reported on a patient with rheumatic in-
volvement of all valves treated with repeated operations,
with a good long-term outcome. These 2 cases demonstrate
that quadruple valve surgery can be successfully performed.
Although the addition of pulmonary valve replacement adds
to the complexity of the operation, previous investigators
have demonstrated good long-term results with triple valve
surgery.5
Our patient made a good recovery from a large and com-
plex operation, despite several severe comorbidities before
surgery and his complicated postoperative course. We think
his recovery justifies such aggressive surgical therapy in se-
lected patients with quadruple valve disease.
CONCLUSIONS
Replacement of all 4 heart valves in 1 operation is feasible
in selected patients. Even in patients with endocarditis, a sat-
isfactory outcome can be achieved.
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FIGURE 2. Severe endocarditis of the tricuspid valve (1) and suspected
endocarditis of the mitral valve with moderate insufficiency (2). LA, Left
atrium; RA, right atrium; LV, left ventricle; RV, right ventricle.
Brief CommunicationsA new miniaturized cardiopulmonary bypass system reduces
transfusion requirements during neonatal cardiac surgery: Initial
experience in 13 consecutive patients
Andreas Koster, MD,a Michael Huebler, MD,b Wolfgang Boettcher, ECCP,c Mathias Redlin, MD,a Felix Berger, MD,d and
Roland Hetzer, MD,b Berlin, GermanyThe potential detrimental effects of the transfusion of autolo-
gous blood products on patients’ outcome is increasingly
appreciated.1,2 This has promoted strategies to reduce the
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tions assessing lower ‘‘critical’’ hemoglobin values as a trig-
ger for transfusions.3 However, particularly in small infants
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Brief Communicationsand neonates, the goal of transfusion-free cardiovascular
surgery is usually limited by the extreme hemodilution
caused by the relatively large priming volume of the
cardiopulmonary bypass (CPB) system. During recent years,
we have demonstrated that implementation of small compo-
nents in the CPB circuit resulting in reduction of the CPB
priming volume facilitated transfusion-free cardiovascular
surgery in selected cases in neonates and small infants.4
Here we report our first experiences with a new miniature
oxygenator and arterial filter system that further significantly
reduces the priming volume of our neonatal CPB circuit.
CLINICAL SUMMARY
After approval by the local ethics committee and having
obtained informed consent from the parents, we analyzed
the data of 13 consecutive neonates (age28 days) who un-
derwent cardiovascular surgery at our institution with the
new CPB setup.
The new CPB system differs from our previously de-
scribed setup on the mast-mounted pediatric console (Sto¨ck-
ert, Munich, Germany) by incorporation of the KIDS D100
oxygenator (Sorin, Mirandola, Italy) and the new arterial fil-
ter line D 130 (Sorin; Figure 1).4 Using this modified setup,
the total priming volume of the CPB was reduced from 200
mL to 110 mL. The surgical procedures and baseline data are
detailed in Table 1. In all procedures a pump flow of 2.5 to 3
L/m2 was maintained with the aid of vacuum-assisted drain-
age. In accordance with departmental standards, during
CPB, the critical hemoglobin value was 7 g/dL, and after
CPB, under the conditions of normothermia (36C–37C)
and normovolemia (atrial filling pressures, 8–12 mm Hg)
and depending on the overall clinical situation of the patient,
the hemoglobin value was 8 to 10 g/dL in patients undergo-
ing anatomic correction and 12 to 16 g/dL in cyanotic pa-
tients undergoing palliative procedures. During the
operation, regional oxygenation was monitored by means
of near-infrared spectroscopy optodes placed on the fore-
head and leg. After CPB, the circuit was flushed with saline,
and the volume was processed with a small-volume cell
bowl (55 mL; Dideco, Mirandola, Italy).
The results are shown in Table 1. The clinical course of all
patients was uneventful. In all patients regional tissue oxy-
genation obtained through near-infrared spectroscopy was
comparable with that in other uneventful procedures per-
formed at our institution, and the tissue oxygenation index
ranged between 75% and 45%.5 In all patients the hemoglo-
bin values obtained after initiation of CPB approximated the
values calculated before CPB. Because of low baseline he-
moglobin values, in 2 patients the CPB was primed with
packed red blood cells. In 5 further patients, administration
of packed red blood cells was necessary during the further
course of CPB. Overall, transfusions were necessary in 7 pa-
tients, whereas in 6 patients (Figure 2) the operation could be
performed without the use of any blood products. In only1566 The Journal of Thoracic and Cardiovascular Suone of these patients was the hemoglobin value in the critical
area of 7 g/dL; in all other patients it was maintained in the
range of 8 to 10 g/dL (Figure 2). However, 4 of these patients
received transfusions during the further course. This is at-
tributable to a postoperative decrease in the hemoglobin
value as a result of postoperative drainage or blood sam-
pling.
DISCUSSION
The current data demonstrate that with the use of a minia-
ture CPB system, the goal of transfusion-free cardiovascular
surgery can be accomplished, even in the smallest neonates
undergoing complex CPB procedures. This particularly ap-
plies to the subgroup of patients undergoing corrective pro-
cedures because 70% of these patients required no
transfusions, whereas all patients with a cyanotic malforma-
tion who underwent palliative procedures received transfu-
sions.
FIGURE 1. The miniaturized CPB system. The double roller pumps are
mast-mounted remote pump heads that can be positioned almost unrestrict-
edly. The arterial pump is placed very close to the outlet of the venous res-
ervoir and to the inlet of the oxygenator/heat exchanger (priming volume, 31
mL). The arterial line filter has a priming volume of 16 mL. The cardiotomy
suction pumps are in proximity to the cardiotomy reservoir inlets. All tubing
connections have internal diameters of 3/16 inch, with the exception of the
segment of the arterial pump, which consists of 1/4-inch silicone tubing.rgery c June 2009
Brief CommunicationsTABLE 1. Surgical procedures and clinical data
Diagnosis Procedure
Pall
iation
Weight
(kg)
Hb
before
CPB (g/dL)
Calculated
Hb
(new/old*
CPB; g/dL)
Hb on
CPB
(g/dL)
Duration
of CPB (min)
Temperature
(C)
Hb after
operation (g/dL) Transfusion
TGA Arterial
switch
operation
No 1.7 13.1 7.8/5.3 7.4 137 26 11.0 No
TA, VSD DKS
procedure
Yes 2.9 11.1 7.7/5.8 8.3 74 30 13.7 1 PRBC 1 FFP
PA RVOT patch Yes 3 11.4 8/6.0 6.4 98 24 13.0 1 PRBC 1 FFP
TGA Arterial
switch
operation
No 3 12.0 8.4/6.2 8.3 103 28 10.2 No
HLHS Norwood
I procedure
Yes 3.2 13.9 10/7.3 10.6 121 12 14.5 1 PRBC 1 FFP
1 RDPC
PA, VSD VSD closure,
AP shunt
Yes 3.3 13.3 9.4/7.4 14.8 43 34 14.1 1 PRBC 1 FFP
TAPVD Correction No 2.9 11.5 9.7/5.9 8.6 70 16 10.0 No
HAA Correction No 3.3 15 10.1/7.8 10.0 130 16 11.5 No
HAA,
VSD
Correction No 2.1 12.5 9.0/4.0 10.1 117 14 12.7 1 PRBC 1 FFP
HAA,
ASD
Correction No 2.8 14.4 9.8/7.0 8.8 108 20 11.0 Yes
TGA,
VSD
Arterial
switch
operation,
VSD closure
No 3.1 12.3 8.7/6.2 9.5 108 24 8.2 No
HAA,
VSD,
ASD
Patch
correction
No 2.4 16.0 10.3/7.2 9.7 133 12 13.8 1 PRBC 1 FFP
1 RDPC
IAA,
VSD
Resection,
correction
No 4.1 14.5 9.4/8.0 10.1 129 14 13.1 No
Hb, Hemoglobin; CPB, cardiopulmonary bypass; TGA, transposition of great arteries; TA, tricuspid valve atresia; VSD, ventricular septal defect; DKS, Damus–Kaye–Stansel pro-
cedure; PRBC, packed red blood cell concentrate; FFP, fresh frozen plasma; PA, pulmonary artery atresia; RVOT, right ventricular outflow tract; HLHS, hypoplastic left heart
syndrome; RDPC, random donor platelet concentrate; VSD, ventricular septal defect; AP, aortopulmonary; TAPVD, total anomaly of the pulmonary venous drainage; HAA, hy-
poplastic aortic arch; ASD, atrial septal defect; IAA, interrupted aortic arch. *Calculated in relation to the priming volume of 200 mL of our former neonatal circuit:
Expected hemoglobin ¼ Current hemoglobin3Patient0s blood volume ðLÞ=Blood volume ðLÞþPriming ðLÞ.Our formerly used small neonatal CPB setup requires
a priming volume of only 200 mL, which is fairly low com-
pared with currently published data with priming volumes of
around 330 mL.6,7 Based on the hemoglobin values before
initiation of CPB, use of this system would have required
a sanguine priming volume in almost all of the patients (Ta-
ble 1), and the probability of need for transfusions during the
further course of the operation in the remaining patients
would have been high. Therefore we conclude that the
new CPB setup considerably contributed to the success in
the 6 patients.
Our data provide convincing evidence that stringent
downsizing of the CPB system, while incorporating all stan-
dard safety features, facilitates transfusion-free cardiac sur-
gery, even in complex neonatal procedures. Although
some patients required transfusions during the further clini-
cal course, we believe that this strategy might effectively
contribute to an overall reduction in the number of patientsThe Journal of Thoracic and CFIGURE 2. Course of hemoglobin values in patients without transfusions.
CPB, Cardiopulmonary bypass; X-clamp, crossclamp; ICU, intensive care
unit.ardiovascular Surgery c Volume 137, Number 6 1567
Brief Communicationsrequiring any transfusion and in the total number of foreign
donor blood exposures.
We thank Anne Gale for editorial assistance.
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Mitral valve repair with artificial chordae is a widely ac-
cepted procedure for the majority of patients with degenera-
tive mitral regurgitation (MR), rendering good long-term
results.1 A new technique for the treatment of extensive mi-
tral prolapse/flail is described herein.
CLINICAL SUMMARY
After median sternotomy, cardiopulmonary bypass is es-
tablished between the right atrium and the aorta. The pericar-
dium is opened, and the apex is elevated with stay sutures. A
purse-string suture is placed onto the posterior aspect of the
left ventricular (LV) apex. The LV apex is punctured with
the Seldinger technique through the string suture, and an
8F introducer sheath is placed into the LV cavity. After
cross-clamping of the aorta and normothermic cardioplegia,
the left atrium (LA) is opened in the usual manner. Two dou-
ble-armed pledgeted 2-0 Prolene sutures (Ethicon, Somer-
ville, NJ) are passed through the prolapsed/flail leaflet
segment and traversed through the LV sheath out of the
left ventricle. The heart is deaired, the LA is closed, and
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the aortic crossclamp is removed. A custom-made polymer
elastic tube of premeasured length and a 2-mm external pro-
file is advanced over the exteriorized suture arms to contact
the target leaflet, thereby securing the suture loops to the
leaflet on the beating heart and thus replacing intracardiac
knotting (Figure 1A). The introducer sheath is removed,
and the LV entry site is closed with a custom-made polymer
occluder placed over the suture arms. The sutures are pulled
and released until a good coaptation of the prolapsed/flail
segment is achieved on the beating heart with transesopha-
geal echocardiographic (TEE) guidance (Figure 1B). The
exteriorized suture lengths are locked with the separate loop
knot and secured to the exterior of the myocardial entry
site occluder (Figure 2).
BetweenMarch and December 2007, 6 male patients aged
64 to 73 years with extensive prolapse, flail, or both of the
posterior (n ¼ 4) and anterior (n ¼ 2) mitral leaflets under-
went mitral repair with the described procedure. All 6 pa-
tients had significant heart failure (New York Heart
Association class III–IV) caused by severe MR 2 to 6 weeks
before surgical intervention. Degenerative mitral disease
was present in all, although only 1 patient had concomitant
coronary artery disease treated with percutaneous interven-
tion. The mitral annulus and the LA were not significantly
enlarged in any of the patients. Informed consent was
obtained from each patient. The procedure was approved by
the institutional review board. No other interventions were
performed during the operation. Cardiopulmonary bypass
time ranged from 40 to 70 minutes, and aortic cross-clamp
time ranged from 5 to 15 minutes. MR was abolished in 2
urgery c June 2009
